ArticlePloS one2022

Enflicoxib for canine osteoarthritis: A randomized, blind, multicentre, non-inferiority clinical trial compared to mavacoxib.

Marta Salichs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.